One in a hundred million: Merkel cell carcinoma in pediatric and young adult patients is rare but more likely to present at advanced stages based on US registry data - 16/05/19
Doi : 10.1016/j.jaad.2018.08.021
Kelly G. Paulson, MD, PhD a, b, c, Paul Nghiem, MD, PhD a, b, c, ⁎ 
a Fred Hutchinson Cancer Research Center, Seattle, Washington
b Seattle Cancer Care Alliance, Seattle, Washington
c University of Washington, Seattle, Washington
∗Correspondence to: Paul Nghiem, MD, PhD, University of Washington, 850 Republican St, Seattle, WA 98109University of Washington850 Republican StSeattleWA98109
| Funding sources: Supported in part by National Institutes of Health/National Cancer Institute grants T32CA009515 and K24-CA139052 and the Merkel Cell Carcinoma Gift Fund at the University of Washington. |
|
| Disclosure: Dr Nghiem reports honoraria from EMD Serono, Merck Sharp and Dohne, Pfizer, Mallinckrodt, Amgen, Incyte, and Takeda and grants and/or research funding to his institution from EMD Serono and Bristol-Myers Squibb. Dr Paulson receives research funding to her institution from Merck. |
|
| Reprints not available from the authors. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 80 - N° 6
P. 1758-1760 - juin 2019 Retour au numéro
Article précédent
- Long-term sheltering mustaches reduce incidence of lower lip actinic keratosis
- Deede Y. Liu, Muhammad I. Gul, Jo Wick, Anand N. Rajpara, Prescilia Isedeh, Ting Wang, Daniel J. Aires
- Online communications among hidradenitis suppurativa patients reflect community needs
- Nicole M. Golbari, Martina L. Porter, Alexa B. Kimball
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?